Julie Rachline
Chief Executive Officer at BrainTale SAS
Network origin in Julie Rachline first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
12
| Public Company | Pharmaceuticals: Generic | 12 |
Turenne Capital Partenaires SA
 Turenne Capital Partenaires SA Investment ManagersFinance Turenne Capital Partenaires SA (Turenne Capital) is a venture capital subsidiary of Turenne Associés SA founded in 1999 by Aymard de Lasteyrie. The firm is headquartered in Paris, France.
9
| Subsidiary | Investment Managers | 9 |
BrainTale SAS
 BrainTale SAS Packaged SoftwareTechnology Services BrainTale SAS engages in the development and distribution of diagnosis and prognosis tools for brain injured patients. Its products include BrainQuant and BrainScore-coma. The company was founded by Vincent Perlbarg, Julie Rachline, Didier Cassereau, Louis Puybasset, Damien Galanaud, and Lionel Velly on July 6, 2018 and is headquartered in Paris, France.
7
| Holding Company | Packaged Software | 7 |
Matignon Investissement et Gestion SAS
 Matignon Investissement et Gestion SAS Investment ManagersFinance Matignon Investissement et Gestion SAS (MIG) is an independent management-owned private equity investment firm based in Paris. MIG was established in 1996 through a management buy-out of Acmer from Banque Worms, formerly part of AXA-UAP and acquired by Deutsche Bank AG in 2001. Following the acquisition, Acmer was delisted. MIG manages private equity and venture capital funds, both generalist and sector specific.
4
| Private Company | Investment Managers | 4 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Julie Rachline via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| École des Hautes Études Commerciales de Paris | College/University | Masters Business Admin Masters Business Admin Undergraduate Degree Masters Business Admin | |
| VALERIO THERAPEUTICS | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chairman | |
| ALTUR INVESTISSEMENT | Investment Managers | Corporate Officer/Principal Chief Investment Officer Corporate Officer/Principal | |
| Université Paris 1 Panthéon-Sorbonne | College/University | Graduate Degree Masters Business Admin | |
| SUPERSONIC IMAGINE | Medical Specialties | Director/Board Member Director/Board Member | |
HRA Pharma Development SARL
 HRA Pharma Development SARL Pharmaceuticals: MajorHealth Technology HRA Pharma Development SARL develops medicines and products for women's health and endocrinology. It offers emergency contraception, uterine fibroids, regular contraception, intimate health, genital herpes, and Lysosafe service. The company was founded by André Ulmann in 1996 and is headquartered in Châtillon, France. | Pharmaceuticals: Major | Director/Board Member Founder | |
| SHIRE | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Synt:em SA
 Synt:em SA Pharmaceuticals: MajorHealth Technology Synt:em SA researches and manufactures drugs for the treatment of pain and cancer. The company specializes in the discovery and development of Central Nervous System (CNS) medicines and novel therapeutics for the treatment diseases. It was founded in 1995 by Michel Kaczorek and Caroline Roussel and is headquartered in Nîmes, France. | Pharmaceuticals: Major | Corporate Officer/Principal Founder | |
| NANOBIOTIX | Medical Specialties | Director/Board Member Director/Board Member | |
Arterial Remodelling Technologies SA
 Arterial Remodelling Technologies SA Pharmaceuticals: MajorHealth Technology Arterial Remodelling Technologies SA develops bioresorbable peripheral and coronary polymer stents. Its products includes ART PBS scaffold, procedure and Clinical data. The company was founded by Antoine Lafont, Michel Vert and J. Frederick Cornhill in 2001 and is headquartered in Paris, France. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| METABOLIC EXPLORER | Chemicals: Specialty | Director of Finance/CFO Director/Board Member | |
Laboratoire HRA-Pharma SA
 Laboratoire HRA-Pharma SA Pharmaceuticals: MajorHealth Technology Laboratoire HRA Pharma SA manufactures and distributes pharmaceutical products. Its products include contraceptive pills such as the pill of two days later and EllaOne. The company was founded by Andre Ulmann in 1996 and is headquartered in Paris, France. | Pharmaceuticals: Major | Founder | |
| University of Paris Jussieu | College/University | Doctorate Degree | |
| FERMENTALG | Food: Specialty/Candy | Director of Finance/CFO | |
| Academy of Athens | Corporate Officer/Principal | ||
| European Molecular Biology Organization | Corporate Officer/Principal | ||
Cellzome Ltd.
 Cellzome Ltd. Pharmaceuticals: MajorHealth Technology Cellzome Ltd. engages in the research, development, and manufacture of pharmaceutical products. It provides kinase-targeted drugs to treat inflammatory diseases. The company was founded by Gitte Neubauer on December 22, 2003 and is headquartered in Middlesex, the United Kingdom. | Pharmaceuticals: Major | Founder | |
Cambridge Philosophical Society
 Cambridge Philosophical Society Investment Trusts/Mutual FundsMiscellaneous The Cambridge Philosophical Society provides grant making services. | Investment Trusts/Mutual Funds | Corporate Officer/Principal | |
| Cemag Consulting | Chief Executive Officer | ||
| ASARINA PHARMA AB | Pharmaceuticals: Major | Director/Board Member | |
Anadys Pharmaceuticals, Inc.
 Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ. | Pharmaceuticals: Major | Founder | |
Cemag SAS
 Cemag SAS Miscellaneous Commercial ServicesCommercial Services Cemag SAS is a French company that specializes in research and development of physical and natural sciences. The private company is based in Paris, France. | Miscellaneous Commercial Services | Chairman | |
| Cemag-Care SA | Founder | ||
| Physip SA | Director/Board Member | ||
| Institut d'Optique Graduate School | College/University | Undergraduate Degree | |
| VALEO | Auto Parts: OEM | Chief Tech/Sci/R&D Officer | |
| National Aeronautics & Space Administration | General Government | Corporate Officer/Principal | |
Paluel-Marmont Capital SA
 Paluel-Marmont Capital SA Investment ManagersFinance Paluel-Marmont Capital SA (PMC) is the wholly-owned private equity subsidiary of Compagnie Lebon (XP: LBON) in France. Formerly known as Lebon Développement, the firm was established in 1991. Located in Paris, PMC invests their own equity in leveraged buy-outs in small- and mid-size businesses, sharing their professional expertise and business network with investee company management. | Investment Managers | Director/Board Member | |
Geneo Capital Entrepreneur SA
 Geneo Capital Entrepreneur SA Investment ManagersFinance Geneo Capital Entrepreneur SA is an Independent Private Equity/Venture Capital firm founded in 2018 by Fanny Letier. Geneo Capital Entrepreneur SA is headquartered in Neuilly-sur-Seine. | Investment Managers | Private Equity Investor | |
| AMERICAN PACIFIC CORPORATION | Chemicals: Major Diversified | Director/Board Member | |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Cellzome, Inc.
 Cellzome, Inc. Pharmaceuticals: MajorHealth Technology Part of GSK Plc, Cellzome, Inc. develops immune-inflammation therapy. The company is based in Philadelphia, PA. The company was founded by Spyridon Artavanis-Tsakonas, Stelios Papadopoulos. | Pharmaceuticals: Major | Founder | |
Massachusetts General Hospital Cancer Center
 Massachusetts General Hospital Cancer Center Hospital/Nursing ManagementHealth Services Massachusetts General Hospital Cancer Center operates as cancer treatment center. The company was founded by John Warren in 1811 and is headquartered in Boston, MA. | Hospital/Nursing Management | Corporate Officer/Principal | |
Sund Capital ApS
 Sund Capital ApS Financial ConglomeratesFinance Sund Capital ApS provides investment services. The private company is based in Copenhagen, Denmark. | Financial Conglomerates | Chief Executive Officer | |
| ZEALAND PHARMA A/S | Pharmaceuticals: Major | Chief Executive Officer | |
Vital Sensors Holding Co., Inc.
 Vital Sensors Holding Co., Inc. Electronic Equipment/InstrumentsElectronic Technology Vital Sensors Holding Co., Inc. Develops chip based pressure sensors. It offers continuous or on demand data capture and read out capabilities that will support clinicians and patients in the management of cardiovascular and other disease state. The company was founded in 2002 by Volker Bödecker and Max Georg Ostermeier and is headquartered in Richmond, VA. | Electronic Equipment/Instruments | Chief Operating Officer | |
Remedy Pharmaceuticals, Inc.
 Remedy Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Remedy Pharmaceuticals, Inc. develops and commercializes pharmaceutical ingridients. It focuses on small molecule drugs for acute central nervous system disorders. The company was founded by David M. Geliebter and Sven M. Jacobson in 2004 and is headquartered in New York, NY. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Critical Care Diagnostics, Inc.
 Critical Care Diagnostics, Inc. Medical SpecialtiesHealth Technology Critical Care Diagnostics, Inc. develops diagnostic tools. The firm offers Presage, a laboratory assay employing ST2 for the diagnosis and prognosis of cardiovascular disease. It also offers Aspect-PLUS ST2 test, a cardiac biomarker testing product that aids clinicians in assessing risk, making treatment decisions, evaluating therapy effectiveness, and monitoring patient care. The company was founded by Sven M. Jacobson and David M. Geliebter in 2004 and is headquartered in San Diego, CA. | Medical Specialties | Chief Tech/Sci/R&D Officer | |
American Chamber of Commerce In Denmark
 American Chamber of Commerce In Denmark Miscellaneous Commercial ServicesCommercial Services The American Chamber of Commerce in Denmark is an organization that provides news, events, membership forums, and resources related to business in Denmark. The American Chamber of Commerce in Denmark is based in Copenhagen, Denmark. The organization focuses on promoting transatlantic data flows and foreign direct investments. Recently, the Danish government announced that it will invest 143 billion kroner in defense over the next decade. The organization also holds more than 50 events a year, including seminars and workshops on topics such as workforce planning and Danish taxation for expats. | Miscellaneous Commercial Services | Director/Board Member | |
| Weill Cornell Medical College | College/University | Doctorate Degree | |
| TXCELL | Miscellaneous Commercial Services | Director/Board Member | |
| The Cass Foundation | Director/Board Member | ||
| AKARI THERAPEUTICS, PLC | Biotechnology | Chief Executive Officer | |
Institut Curie
 Institut Curie Miscellaneous Commercial ServicesCommercial Services Institut Curie engages as a non-profit foundation. It operates a research center on biophysics, cell biology, and oncology and a hospital specialized in treatment of cancer. The company was founded in 1909 and is headquartered in Paris, France. | Miscellaneous Commercial Services | Director/Board Member | |
| SILENCE THERAPEUTICS PLC | Miscellaneous Commercial Services | Chief Executive Officer |
Statistics
International
| France | 25 |
| United States | 14 |
| United Kingdom | 5 |
| Denmark | 4 |
| Ireland | 2 |
Sectoral
| Health Technology | 23 |
| Consumer Services | 6 |
| Commercial Services | 6 |
| Finance | 5 |
| Process Industries | 3 |
Operational
| Director/Board Member | 91 |
| Corporate Officer/Principal | 53 |
| Chairman | 30 |
| Founder | 23 |
| Private Equity Investor | 23 |
Most connected contacts
| Insiders | |
|---|---|
| Jean-Michel Petit | 24 |
| Catherine Dunand | 23 |
| David Solomon | 22 |
| Paul Michalet | 16 |
| Spyridon Artavanis-Tsakonas | 15 |
| Stéphane Delplancq | 14 |
| Christophe Douat | 13 |
| Charlotte Sibley | 13 |
| Luc-André Granier | 12 |
| Quentin Jacomet | 12 |
| Thierry Chignon | 11 |
| André Ulmann | 11 |
| Hege Hellstrom | 11 |
| Guillaume Connan | 10 |
| Nitza Thomasson-Perret | 9 |
- Stock Market
- Insiders
- Julie Rachline
- Company connections
